메뉴 건너뛰기




Volumn 8, Issue 3, 2002, Pages 287-289

Direct antithrombin agents ameliorate disseminated intravascular coagulation in suspected heparin-induced thrombocytopenia thrombosis syndrome

Author keywords

Direct antithrombins; Disseminated intravascular coagulation

Indexed keywords

ANTITHROMBIN; ARGATROBAN; HEPARIN; LEPIRUDIN;

EID: 0036657771     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800314     Document Type: Article
Times cited : (9)

References (11)
  • 1
    • 0033543081 scopus 로고    scopus 로고
    • Lepirudin [recombinant hirudin] for parenteral anticoagulation in patients with heparin-induced thrombocytopenia
    • Heparin-Associated Thrombocytopenia Study [HAT] investigators
    • Greinacher A, Janssens U, Berg G, et al. Lepirudin [recombinant hirudin] for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study [HAT] investigators. Circulation 1999;100:587.
    • (1999) Circulation , vol.100 , pp. 587
    • Greinacher, A.1    Janssens, U.2    Berg, G.3
  • 2
    • 0345369740 scopus 로고    scopus 로고
    • Recombinant hirudin [lepirudin] provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study
    • Greinacher A, Volpel H, Janssens U, et al. Recombinant hirudin [lepirudin] provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study. Circulation 1999;99:73.
    • (1999) Circulation , vol.99 , pp. 73
    • Greinacher, A.1    Volpel, H.2    Janssens, U.3
  • 3
    • 0030611555 scopus 로고    scopus 로고
    • Anticoagulation with Novastan [argatroban] in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome
    • Lewis BE, Walenga JM, Wallis DE. Anticoagulation with Novastan [argatroban] in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Semin Thromb Hemost 1997;23:197.
    • (1997) Semin Thromb Hemost , vol.23 , pp. 197
    • Lewis, B.E.1    Walenga, J.M.2    Wallis, D.E.3
  • 4
    • 0031793581 scopus 로고    scopus 로고
    • New treatment options for heparin-induced thrombocytopenia
    • Ortel TL, Chong BH. New treatment options for heparin-induced thrombocytopenia. Semin Hematol 1998;35:26.
    • (1998) Semin Hematol , vol.35 , pp. 26
    • Ortel, T.L.1    Chong, B.H.2
  • 5
    • 0023575695 scopus 로고
    • Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats
    • Hauptmann J, Bruggener E, Marwardt F. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats. Haemostasis 1987;17:321.
    • (1987) Haemostasis , vol.17 , pp. 321
    • Hauptmann, J.1    Bruggener, E.2    Marwardt, F.3
  • 6
    • 0031951289 scopus 로고    scopus 로고
    • Endotoxin-induced disseminated intravascular coagulation in rabbits: Effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality
    • Hermida J, Montes R, Parmo JA, Rocha E. Endotoxin-induced disseminated intravascular coagulation in rabbits: Effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality. J Lab Clin Med 1998;131:77.
    • (1998) J Lab Clin Med , vol.131 , pp. 77
    • Hermida, J.1    Montes, R.2    Parmo, J.A.3    Rocha, E.4
  • 7
    • 0024563896 scopus 로고
    • Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis
    • Krupinski K, Breddin HK, Markward F, Haarmann W. Antithrombotic effects of three thrombin inhibitors in a rat model of laser-induced thrombosis. Haemostasis 1989;19:74.
    • (1989) Haemostasis , vol.19 , pp. 74
    • Krupinski, K.1    Breddin, H.K.2    Markward, F.3    Haarmann, W.4
  • 8
    • 0022157752 scopus 로고
    • Effect of MD-805, a synthetic thrombin inhibitor on disseminated intravascular coagulation developing in hematological disorders
    • Higuchi M, Kunitomi O, Nishida Y, et al. [Effect of MD-805, a synthetic thrombin inhibitor on disseminated intravascular coagulation developing in hematological disorders]. Rinsho Ketsueki 1985;26:1754.
    • (1985) Rinsho Ketsueki , vol.26 , pp. 1754
    • Higuchi, M.1    Kunitomi, O.2    Nishida, Y.3
  • 9
    • 0021715046 scopus 로고
    • Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation
    • Kumon Y, Tanaka K, Nakjima N, et al. Anticoagulation with a synthetic thrombin inhibitor after cardiovascular surgery and for treatment of disseminated intravascular coagulation. Crit Care Med 1984;12:1039.
    • (1984) Crit Care Med , vol.12 , pp. 1039
    • Kumon, Y.1    Tanaka, K.2    Nakjima, N.3
  • 10
    • 0028918568 scopus 로고
    • Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy
    • Saito M, Asakura H, Jakaji H, et al. Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy. Blood Coagul Fibrinolysis 1995;6:60.
    • (1995) Blood Coagul Fibrinolysis , vol.6 , pp. 60
    • Saito, M.1    Asakura, H.2    Jakaji, H.3
  • 11
    • 0021015051 scopus 로고
    • A clinical trial of MD-805, a synthetic thrombin inhibitor, for the treatment of DIC
    • Yamada K. A clinical trial of MD-805, a synthetic thrombin inhibitor, for the treatment of DIC. Bibl Haematol 1983;49:343.
    • (1983) Bibl Haematol , vol.49 , pp. 343
    • Yamada, K.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.